scholarly journals Capsule Endoscopy in Patients with Cardiac Pacemakers, Implantable Cardioverter Defibrillators, and Left Heart Devices: A Review of the Current Literature

2011 ◽  
Vol 2011 ◽  
pp. 1-6 ◽  
Author(s):  
Dirk Bandorski ◽  
Martin Keuchel ◽  
Martin Brück ◽  
Reinhard Hoeltgen ◽  
Marcus Wieczorek ◽  
...  
Keyword(s):  
Capsule Endoscopy ◽  
In Vivo Studies ◽  
Implantable Cardioverter Defibrillators ◽  
Left Heart ◽  
Cardiac Pacemakers ◽  
Technical Data ◽  
Cardiac Devices ◽  
Cardioverter Defibrillators

Background and Study Aims. Capsule endoscopy is an established tool for investigation of the small intestine. Because of limited clinical experience in patients with cardiac devices, the Food and Drug Administration and the manufacturer recommended not to use capsule endoscopy in these patients. The vast majority of investigations did not reveal any interference between capsule endoscopy and cardiac devices. Methods. Studies investigating interference between CE and cardiac devices were analysed. For the review we considered studies published in English or German and indexed in Medline, as well as highly relevant abstracts. Results. In vitro and in vivo studies mainly revealed no interference between capsule endoscopy and cardiac devices. Technical data of capsule endoscopy (Given Imaging) reveal that interference with cardiac pacemakers and implantable cardioverter defibrillator is impossible. Telemetry can interfere with CE video. Conclusion. The clinical use of capsule endoscopy (Given Imaging) is unproblematic in patients with cardiac pacemakers.

scholarly journals Safety Profile of Liver FibroScan in Patients with Cardiac Pacemakers or Implantable Cardioverter-Defibrillators

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
Yin Chan ◽  
Stephanie Pranke ◽  
Farid Rashidi ◽  
Shravan Nosib ◽  
Lawrence Worobetz
Keyword(s):  
Safety Profile ◽  
Liver Stiffness ◽  
Clinical Signs ◽  
Liver Imaging ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Pacemakers ◽  
Nonalcoholic Fatty Liver ◽  
Cardiac Devices ◽  
Imaging Results ◽  
Cardioverter Defibrillators

Background. Emerging evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated with coronary artery diseases and arrhythmias. The FibroScan (Echosens, France), a widely available, noninvasive device, is able to detect liver fibrosis and steatosis within this patient population. However, the FibroScan is currently contraindicated in patients with cardiac pacemakers (PM) or implantable cardioverter-defibrillators (ICD).Objective. To determine the safety profile of FibroScan testing in patients with PM or ICD.Methods. Consecutive outpatients undergoing routine device interrogations at a tertiary level teaching hospital underwent simultaneous liver stiffness measurements. PM or ICD performance data, device types, patient demographics, medical history, and previous laboratory and conventional liver imaging results were collected.Results. Analysis of 107 subjects with 33 different types of implanted cardiac devices, from 5 different companies (Medtronic, Sorin, ELA Medical, Boston Scientific, and St. Jude), did not demonstrate any adverse events as defined by abnormal device sensing/pacing or ICD firing. This population included high risk subjects undergoing active pacing (n=53) and with right pectoral PM placement (n=1). None of the subjects had any clinical signs of decompensated congestive heart failure or cirrhosis during the exam.Conclusion. TE with FibroScan can be safely performed in patients with PM or ICD.

MR Imaging and Cardiac Pacemakers: In Vitro Evaluation and in Vivo Studies in 51 Patients at 0.5 T

Radiology ◽  
2000 ◽  
Vol 215 (3) ◽  
pp. 869-879 ◽  
Author(s):  
Torsten Sommer ◽  
Christian Vahlhaus ◽  
Gerhard Lauck ◽  
Alexander v. Smekal ◽  
Marcus Reinke ◽  
...  
Keyword(s):  
Mr Imaging ◽  
In Vivo Studies ◽  
Cardiac Pacemakers ◽  
In Vitro Evaluation

scholarly journals Capsule Endoscopy in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators: (Re)evaluation of the Current State in Germany, Austria, and Switzerland 2010

2012 ◽  
Vol 2012 ◽  
pp. 1-4 ◽  
Author(s):  
Dirk Bandorski ◽  
Ralf Jakobs ◽  
Martin Brück ◽  
Reinhard Hoeltgen ◽  
Marcus Wieczorek ◽  
...  
Keyword(s):  
Capsule Endoscopy ◽  
Cardiac Pacemaker ◽  
Implantable Cardioverter Defibrillators ◽  
Cardiac Pacemakers ◽  
Current State ◽  
Before And After ◽  
Type Of Institution ◽  
Cardioverter Defibrillators ◽  
Repeated Evaluation

Background and Aims. The study was a repeated evaluation of the experience of capsule endoscopy (CE) in patients with cardiac pacemaker or implantable cardioverter defibrillator (ICD).Patients and Methods. A standardized questionnaire was sent by the manufactors Given Imaging and Olympus to all centers in Germany, Austria, and Switzerland providing capsule endoscopy service. The questionnaire covers the number of examined patients, monitoring during CE, check of the electric implants before and after CE, occurrence of arrhythmia, quality of CE video, complications, indication of CE, and type of institution.Results. Overall 580 questionnaires were sent to the users. 26/5% (Germany/Austria + Switzerland) of the questionnaires were sent back anonymously to the authors. 114 centers (82 hospitals, 11 surgeries, 21 without specification) replied. In 58 centers (51%), patients with cardiac pacemaker (n=300) and ICDs (n=80) underwent uneventful capsule endoscopy. The predominant indication (patients with CP 97%, patients with ICD 100%) was mid gastrointestinal bleeding.Conclusion. The results of our inquiry show that in spite of formal contraindication CE is increasingly applied in bleeding patients with cardiac pacemakers/ICDs and seems to be safe even in a large cohort.

Sign in / Sign up

Export Citation Format

Share Document